White label ELPA - ClinicalTrials.eu

Study on Thoracic Radiotherapy and Durvalumab for Elderly or Frail Stage III Non-Small Cell Lung Cancer Patients Unable to Undergo Chemotherapy

Not recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
- Durvalumab
Study on Durvalumab and Radiation Therapy for Patients with Recurrent Glioblastoma

Not recruiting

1 1 1 1
Investigated diseases:
- Glioblastoma
Investigated drugs:
- Durvalumab
Study on the Effectiveness and Safety of Clustoid MM09 for Patients with Allergic Rhinitis or Rhinoconjunctivitis, with or without Mild to Moderate Asthma

Not recruiting

3 1
Investigated diseases:
Investigated drugs:
- Dermatophagoides Farinae Allergoid, Glutaraldehyde-Modified
- Dermatophagoides Pteronyssinus Allergoid, Glutaraldehyde-Modified
Long-Term Access to Ibrutinib for Patients with Lymphoma, Leukemia, and Other Conditions

Not recruiting

3 1 1
Investigated diseases:
Investigated drugs:
- Ibrutinib
+1
Study on the Safety and Effectiveness of Adalimumab and Etanercept in Children with Active Juvenile Idiopathic Arthritis

Not recruiting

3 1 1 1
Investigated diseases:
- Juvenile idiopathic arthritis
Investigated drugs:
- Etanercept
- Adalimumab
Study of luspatercept in patients with low-risk myelodysplastic syndrome (MDS) who do not require blood transfusions and have not received erythropoiesis treatment

Not recruiting

2 1 1 1
Investigated diseases:
- Myelodysplastic syndrome
Investigated drugs:
- Luspatercept
Study Comparing Ivonescimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Squamous Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated drugs:
+3
Study Comparing Epcoritamab and Lenalidomide with a Drug Combination for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Not recruiting

3 1 1 1
Investigated diseases:
- Diffuse large B-cell lymphoma
Investigated drugs:
+5
Study on the Effects of Risankizumab in Patients with Very Early Axial Spondyloarthritis

Not recruiting

2 1 1 1
Investigated diseases:
- Axial spondyloarthritis
Investigated drugs:
- Risankizumab
Study of Pemigatinib for Patients with Advanced Intrahepatic Cholangiocarcinoma with FGFR2 Changes After Local Therapy

Not recruiting

2 1 1 1
Investigated diseases:
- Cholangiocarcinoma
Investigated drugs:
- Pemigatinib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies